Tiziana Life Sciences (TLSA) Long-Term Investments (2022 - 2025)
Tiziana Life Sciences (TLSA) posted quarterly Long-Term Investments of $3.7 million for Q2 2025, up 25.67% year-over-year from $3.0 million in Q2 2024, and up 3.96% quarter-over-quarter from $3.6 million in Q4 2024.
Tiziana Life Sciences (TLSA) Long-Term Investments (2022 - 2025) Analysis & Trends
Tiziana Life Sciences' Long-Term Investments history runs 4 years deep, the most recent figure standing at $3.7 million for Q2 2025.
- In Q2 2025, Long-Term Investments rose 25.67% year-over-year to $3.7 million; the TTM figure through Jun 2025 stood at $3.7 million (up 25.67% YoY), while the FY2024 annual figure was $3.6 million, down 21.19% from the prior year.
- Long-Term Investments for Q2 2025 stood at $3.7 million, up from $3.6 million in the prior quarter.
- The five-year high for Long-Term Investments was $4.6 million in Q4 2023, with the low at -$2.7 million in Q4 2022.
- The 4-year median for Long-Term Investments is $3.0 million (2024), against an average of $2.4 million.
- Peak annual rise in Long-Term Investments reached 270.18% in 2023, while the deepest fall reached 29.52% in 2023.
- Tiziana Life Sciences' Long-Term Investments stood at -$2.7 million in 2022, then surged by 270.18% to $4.6 million in 2023, then dropped by 21.19% to $3.6 million in 2024, then climbed by 3.96% to $3.7 million in 2025.
- Business Quant data shows TLSA's Long-Term Investments at $3.7 million in Q2 2025, $3.6 million in Q4 2024, and $3.0 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.77 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.17 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 372.10 Mn |
| 10 | Tiziana Life Sciences | 133.66 Mn | 129.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 3.73 Mn |
| Dec 31, 2024 | 3.59 Mn |
| Jun 30, 2024 | 2.97 Mn |
| Dec 31, 2023 | 4.55 Mn |
| Jun 30, 2023 | 1.89 Mn |
| Dec 31, 2022 | -2.68 Mn |
| Jun 30, 2022 | 2.68 Mn |